AceLink Therapeutics is involved in drug development, focusing on glycolipid biology and rare genetic diseases. The company collaborates with contract research organizations and academic leaders to transform scientific discoveries into therapies.

AceLink Therapeutics

Viva BioInnovator operates as the investment division of Viva Biotech Holdings, focusing on identifying and supporting early-stage biotech companies through investment and incubation.

Viva BioInnovator

AceLink Therapeutics | 437 followers on LinkedIn. Overcome genetic diseases, one at a time | AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associated human diseases with the initial focus on a small molecule drug for polycystic kidney disease (PKD), a human genetic disease with 12 million patients worldwide.

Yuqiao (Jerry) Shen

Metric
Company Name	AceLink Therapeutics	Viva BioInnovator
Symbol
MSH ID	COM:ACELINKTHERAPEUTICS	COM:VIVABIOINNOVATOR
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance
Industry	Biotechnology	Biotechnology
Country	US	HK
Stage	Venture Round
Employee Count
Website	acelinktherapeutics.com/home	vivabioinnovator.com
LinkedIn	acelink-therapeutics	viva-bioinnovator
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1	176
Web Traffic Growth	-1.00	-0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ACEL

COM:ACELINKTHERAPEUTICS

AceLink Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue